IL6 and neoplasm: Mediators of inflammatory pathways such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα), and cyclooxygenase-2 (COX-2) are involved in cancer-related mechanisms that diminish tumor suppressor function, stimulate oncogene expression, and increase cell cycling [103].